ChengDu ShengNuo Biotec Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 161.92 million compared to CNY 181.75 million a year ago. Revenue was CNY 167.51 million compared to CNY 193.64 million a year ago.

Net income was CNY 18.64 million compared to CNY 24.01 million a year ago. Basic earnings per share from continuing operations was CNY 0.1643 compared to CNY 0.2714 a year ago. Diluted earnings per share from continuing operations was CNY 0.1643 compared to CNY 0.2714 a year ago.